<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Inst of Integrative &amp; Comparative Biolog</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E55978B4-6D3F-4696-951D-C9960EC7EFAA"><gtr:id>E55978B4-6D3F-4696-951D-C9960EC7EFAA</gtr:id><gtr:firstName>Joan</gtr:firstName><gtr:surname>Boyes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9900193"><gtr:id>30BC7B85-CF6E-4BC1-8A5A-E5F4222DFD27</gtr:id><gtr:title>Chromatin disruption and the regulation of V(D)J recombination</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9900193</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>810491</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>University Clinic of Munich</gtr:department><gtr:description>Effect of histone acetylation on chromatin remodelling complexes</gtr:description><gtr:id>0ADDA073-3DD0-4014-872B-BA40F0C329F6</gtr:id><gtr:impact>This resulted in the publication by Nightingale et al in 2007</gtr:impact><gtr:partnerContribution>Provided technical expertise to bring research finding to publicationProvided chromatin remodelling complexes to bring research finding to publication</gtr:partnerContribution><gtr:piContribution>We made the initial observation and collaborated with two research groups who had reagents/technical expertise to bring this project to publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre</gtr:department><gtr:description>Analysis of the regulation of a recombination enhancer</gtr:description><gtr:id>ECBEE3DE-11C9-497B-9F5B-2171A9F2E0DA</gtr:id><gtr:impact>Manuscript being revised for re-submission</gtr:impact><gtr:partnerContribution>Provided expertise in experiments and performed one key experiment that contributed to the manuscript that is currently under revision</gtr:partnerContribution><gtr:piContribution>We made the observations about the role of a transcription factor in regulating the enhancer function and analysed the transgenic mice. Most of the experiments were performed in my lab but with some input and advice from our collaborators in London.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>Effect of histone acetylation on chromatin remodelling complexes</gtr:description><gtr:id>D5B8B596-6F03-4D38-8248-43288DC130B1</gtr:id><gtr:impact>This resulted in the publication by Nightingale et al in 2007</gtr:impact><gtr:partnerContribution>Provided technical expertise to bring research finding to publicationProvided chromatin remodelling complexes to bring research finding to publication</gtr:partnerContribution><gtr:piContribution>We made the initial observation and collaborated with two research groups who had reagents/technical expertise to bring this project to publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ESF signalling to chromatin meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C45B5127-F1F7-40C3-B2D6-6DBF41194400</gtr:id><gtr:impact>A 30 minute talk was given to an International audience that included major researchers in the chromatin field

Disseminated research findings to researchers in the field</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chromatin Gordon conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48C195F8-4322-4B87-81BA-4CE968CCD118</gtr:id><gtr:impact>A poster was presented at the major International chromatin meeting. This is the most heavily over-subscribed of all the Gordon conferences and most of the poster presenters were PIs. My poster was judged top by a panel of leading International researchers.

Disseminated research findings to researchers in the field</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>poster presentation</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tenovus Symposium, Scotland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>65D908FC-6A4F-4053-9245-1BE251CC6159</gtr:id><gtr:impact>A 30 minute talk was given to an audience that was primarily from the UK but with some from the rest of Europe and beyond.

Disseminated research findings to researchers in the field</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6114C460-3B85-48BD-B4D2-AD8CC6F9D656</gtr:id><gtr:impact>The work was presented via a poster to parents and students during Univeristy open day

no direct impact known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC PhD Studentship</gtr:description><gtr:end>2008-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>A778EF48-4BE8-4CAE-A952-F0BEDBCBEFDA</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2005-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>144000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>YCR Project Grant</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Yorkshire Cancer Research</gtr:fundingOrg><gtr:fundingRef>L338</gtr:fundingRef><gtr:id>899D98F9-4DEC-4EF2-A2CA-CA8FA08DE20D</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>YCR Equipment grants</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Yorkshire Cancer Research</gtr:fundingOrg><gtr:fundingRef>L443</gtr:fundingRef><gtr:id>56B3BCDA-47DD-4AA3-A284-81F42F27E947</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>395000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0801101</gtr:fundingRef><gtr:id>556EC994-D5DF-45A5-AC55-1DC2510A0EE1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An improved method for analysing active regions in chromatin (hypersensitive sites) was developed and published. Previously, the effects of endogenous nucleases had not been adequately considered; the improved method helps to decrease their impact on hypersensitivity measurements.</gtr:description><gtr:id>E0ED7F7D-34A6-43A1-B5CE-7DA21D7D1E56</gtr:id><gtr:impact>This methodology was made available via its publication. We routinely use this improved technique although it is unclear how many other groups have adopted this modification.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Improved method of hypersensitive site mapping</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic mice that over-express the transcription factors PU.1 or IRF-4/PIP specifically at the pro-B cell stage of development have been generated. The IRF-4/PIP mice induce full activation of immunoglobulin lambda light chain recombination</gtr:description><gtr:id>00E4F817-A4CF-4BD9-BAB8-E118DFD84818</gtr:id><gtr:impact>A manuscript describing this work was published in EMBO J and we will make these reagents available to other researchers who request them.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Transgenic mouse lines - increased expression of transcription factor</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic mouse lines were generated where enhancers of V(D)J recombination were mutated to analyse the mechanism by which the enhancer activates recombination.</gtr:description><gtr:id>C0C170B4-7E74-4129-9E28-731ED7010AFD</gtr:id><gtr:impact>The animals were made available to another research group in 2006. A manuscript published in 2013 resulting from the use of these animals.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic mouse lines</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AC4EB850-0590-4FFC-88BC-2790A6AACF2F"><gtr:id>AC4EB850-0590-4FFC-88BC-2790A6AACF2F</gtr:id><gtr:title>The E?(3-1) enhancer is essential for V(D)J recombination of the murine immunoglobulin lambda light chain locus.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89529b776ed0ac558121b0adab3ec30a"><gtr:id>89529b776ed0ac558121b0adab3ec30a</gtr:id><gtr:otherNames>Haque SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D74DA469-90CE-4711-BB59-E1BF440388AE"><gtr:id>D74DA469-90CE-4711-BB59-E1BF440388AE</gtr:id><gtr:title>Chromatin opening is tightly linked to enhancer activation at the kappa light chain locus.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6489afd551e48469fe469d2dbf829b74"><gtr:id>6489afd551e48469fe469d2dbf829b74</gtr:id><gtr:otherNames>Grange S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17E29225-D011-4BE1-BCC4-EA9E8A8ECC2F"><gtr:id>17E29225-D011-4BE1-BCC4-EA9E8A8ECC2F</gtr:id><gtr:title>Acetylation increases access of remodelling complexes to their nucleosome targets to enhance initiation of V(D)J recombination.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6384ff12c397150905a4b6617716b2f3"><gtr:id>6384ff12c397150905a4b6617716b2f3</gtr:id><gtr:otherNames>Nightingale KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8166590-4B95-4E75-8C45-1A14064DE17C"><gtr:id>E8166590-4B95-4E75-8C45-1A14064DE17C</gtr:id><gtr:title>Transcription-coupled eviction of histones H2A/H2B governs V(D)J recombination.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb311f2d095ebfd5cf2ed7e20f12afff"><gtr:id>fb311f2d095ebfd5cf2ed7e20f12afff</gtr:id><gtr:otherNames>Bevington S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9900193</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>